Category: Proscia
Auto Added by WPeMatico
Agilent to Acquire Proscia for Up to $270M to Build Scientific Intelligence Layer in Digital Pathology
Agilent to Acquire Proscia for Up to $270M to Build Scientific Intelligence Layer in Digital Pathology What You Should Know…
Proscia Integrates with AWS HealthImaging to Scale Digital Pathology and AI
Proscia Integrates with AWS HealthImaging to Scale Digital Pathology and AI What You Should Know: – Proscia, a pathology AI…
Bonus Features – September 14, 2025 – One-third of patients find incorrect information in provider directories, 39% of patients avoid seeking care if it means finding a new doctor, plus 32 more stories
Bonus Features – September 14, 2025 – One-third of patients find incorrect information in provider directories, 39% of patients avoid…
Proscia Launches AI Solution to Advance Precision Medicine
Proscia Launches AI Solution to Advance Precision Medicine What You Should Know: – Proscia®, a pathology AI company, has announced…
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer What You Should Know: – Owkin, an AI-biotech company specializing…
Fimlab Partners with Proscia to Advance AI-Enabled Digital Pathology
Fimlab Partners with Proscia to Advance AI-Enabled Digital Pathology What You Should Know: – Fimlab Laboratories, a provider of laboratory…
Spectrum Taps Proscia to Modernize its Pathology Operations
Spectrum Taps Proscia to Modernize its Pathology Operations – Proscia®, a leading provider of digital and computational pathology solutions, today…
PathGroup Expands Operations with Proscia Concentiq Dx
PathGroup Expands Operations with Proscia Concentiq Dx What You Should Know: – PathGroup, one of the largest providers of anatomic, clinical,…
PathGroup Expands Operations with Proscia Concentiq Dx
PathGroup Expands Operations with Proscia Concentiq Dx What You Should Know: – PathGroup, one of the largest providers of anatomic, clinical,…
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023? News of Fujifilm’s recent acquisition of…
